Can cortical necrosis of the kidney be detected on renal ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Cortical Necrosis Be Detected on Renal Ultrasound?

Conventional grayscale and Doppler ultrasound cannot specifically diagnose cortical necrosis, but contrast-enhanced ultrasound (CEUS) can reliably detect the pathognomonic peripheral rim sign that confirms this diagnosis. 1

Conventional Ultrasound Limitations

Standard renal ultrasound (grayscale and color Doppler) lacks the ability to specifically diagnose acute cortical necrosis. 1 The ACR Appropriateness Criteria explicitly state that while ultrasound is excellent for detecting hydronephrosis and assessing kidney size, it does not provide the contrast enhancement patterns necessary to identify cortical necrosis. 1

What Conventional Ultrasound Shows:

  • Decreased renal parenchymal vascularization on color Doppler 2
  • Elevated resistive indices (>0.7) in spectral waveforms when detectable 2
  • Nonspecific findings that cannot differentiate cortical necrosis from other causes of acute kidney injury 1

Contrast-Enhanced Ultrasound (CEUS) as the Solution

CEUS demonstrates the characteristic "peripheral rim sign"—a continuous unenhanced cortical band with preserved medullary enhancement—which is pathognomonic for cortical necrosis and matches findings seen on CT and MRI. 2

CEUS Protocol and Findings:

  • After injection of 2.4 mL of second-generation ultrasound contrast agent, evaluate enhancement during arterial, corticomedullary, and nephrographic phases over 4 minutes 2
  • Main renal arteries and medullary pyramids enhance normally 2
  • Peripheral cortex remains completely unenhanced in all phases, creating the diagnostic rim sign 2
  • This finding correlates precisely with pathologic specimens showing hemorrhagic cortical necrosis 3, 2

Clinical Advantages of CEUS:

  • Provides safe, rapid diagnosis without nephrotoxic iodinated contrast 3, 2
  • Allows earlier clinical decision-making, including potential transplantectomy in graft cases 2
  • Stratifies patients with irreversible cortical necrosis from those with potentially reversible acute kidney injury 3

MRI as the Gold Standard

When CEUS is unavailable, MRI with contrast is the preferred non-invasive diagnostic method, showing a low T2 signal rim at the corticomedullary junction and absent cortical enhancement after gadolinium administration. 1, 4

MRI Diagnostic Features:

  • Low T2 signal intensity rim at the corticomedullary junction 1
  • Complete absence of cortical enhancement following contrast administration 1, 4
  • These findings are characteristic and specific for acute cortical necrosis 5
  • MRI provides global assessment of disease extent, unlike kidney biopsy which samples only focal areas 5

Alternative Imaging Modalities

CT with Contrast:

  • Shows the pathognomonic triad: (1) lack of cortical enhancement, (2) preserved medullary enhancement, and (3) absent renal excretion 6
  • Remains a reliable diagnostic method but requires nephrotoxic iodinated contrast 5, 7

Nuclear Medicine:

  • MAG3 scan may show persistent nephrogram without excretion, but this is nonspecific and also seen in acute tubular necrosis 1
  • DMSA scan can show photopenic halo around viable cortex (the "halo sign"), representing cortical loss 7
  • These modalities are not first-line and provide less specific information than CEUS or MRI 7

Clinical Algorithm

For suspected cortical necrosis in acute kidney injury:

  1. If CEUS is available → perform CEUS as first-line imaging 3, 2

    • Positive peripheral rim sign = confirmed cortical necrosis
    • Proceed directly to management without further imaging
  2. If CEUS unavailable → obtain MRI without and with contrast 1, 4

    • Look for low T2 rim and absent cortical enhancement
    • Avoid gadolinium if eGFR <30 mL/min (nephrogenic systemic fibrosis risk)
  3. If MRI contraindicated → consider CT with contrast 6, 7

    • Use only if benefit outweighs nephrotoxicity risk
    • Ensure adequate hydration
  4. Conventional ultrasound alone is insufficient 1

    • May show nonspecific findings but cannot confirm diagnosis
    • Should not delay definitive imaging with CEUS or MRI

Common Pitfalls

  • Ordering standard "renal ultrasound" expecting to diagnose cortical necrosis—this will fail without contrast enhancement 1
  • Confusing decreased Doppler flow with specific diagnosis—elevated resistive indices are nonspecific and seen in multiple conditions 2
  • Relying on kidney biopsy for extent assessment—biopsy provides only focal sampling and misses global disease distribution 5
  • Using iodinated contrast CT in patients with severe AKI—this adds nephrotoxic insult and CEUS or unenhanced MRI are safer alternatives 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Renal Cortical Necrosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

MR imaging features of acute bilateral renal cortical necrosis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000

Research

CT findings in acute renal cortical necrosis.

Journal of computer assisted tomography, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.